Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

TRANSMIT

From Bioblast
Revision as of 12:20, 9 March 2017 by Laner Verena (talk | contribs)

                



TRANSMIT

TRANSMIT - TRANSlating the role of MItochondria in Tumorigenesis
Horizon 2020

TRANSMIT Marie Skłodowska-Curie PhD Fellowship with OROBOROS INSTRUMENTS / Medical University Innsbruck

  • 11 Phd student positoins are open in the TRANSMIT project. OROBOROS offers one PhD position in collaboration with the Medical University of Innsbrucl
  • Find out more, see: INSTRUMENTS
  • Application deadline: April 30
  • OROBOROS MitoFit Research Laboratory


TRANSMIT Call H2020-MSCA-ITN-2016

European commission

Cancer is not only a genetic, but also a metabolic disease

The consolidation of the knowledge that cancer is not only a genetic, but also a metabolic disease, has led scientists to investigate the intricate metabolic plasticity that transformed cells must undergo to survive the adverse tumor microenvironment conditions, and the contribution of oncogenes and tumor suppressors in shaping metabolism. In this scenario, genetic, biochemical and clinical evidence places mitochondria as key actors in cancer metabolic restructuring, not only because these organelles play a crucial role in energy production and formation of biosynthetic intermediates, but also because occurrence of mutations in both nuclear and mtDNA encoding metabolic enzymes is associated with different types of cancer.


Objectives

TRANSMIT aims to dissect the metabolic remodeling in human cancers, placing the focus on the role of mitochondria and bridging basic research to the improvement/development of therapeutic strategies.
TRANSMIT fosters the communication of this emerging field to the patients and their families. Accordingly, TRANSMIT will create a network of seven countries, including world-leading basic science and clinical centers of excellence, several industrial partners with up-to-date technologies, as well as non-profit foundations and associations who care for cancer patients.
By creating the critical mass of scientific excellence, TRANSMIT will allow to transfer the current knowledge into the wide field of cancer research, translating scientific and technical advances to the education and training of eleven Early Stage Researchers. TRANSMIT will implement training-through-research dedicated to unravel the metabolic features of cancer, as well as to provide a full portfolio of complementary skills through the creation of a network of basic, translational and industrial laboratories, devoted to a multidisciplinary/multisectorial education of young scientists.
TRANSMIT key methodologies and key objectives: The project is structured in three scientific WPs. For each WP, several ESRs are recruited as indicated below the WP title. Scientific WPs share the key methodologies indicated within the four sectors of the romboid in light grey. The implementation of key methodologies in pairs allows the achievement of the key objectives indicated by the dark grey arrowheads.
Key methodologies and key objectives


Coordinator

TRANSMIT project coordinator:
Anna-Maria Porcelli
Alma Mater Studiorum – Università di Bologna - IT


TRANSMIT project manager:
Serena Paterlini
Alma Mater Studiorum – Università di Bologna - IT
OROBOROS project manager:
Mag. Verena Laner


Project partners


University of Bologna Universite Catholique de Louvain link=http://wiki.oroboros.at/index.php/OROBOROS_INSTRUMENTS OROBOROS Justus Liebig Universität Giessen Salzburger Landeskliniken Karolinska Institutet Adera Biocrates Life Sciences AG AvantiCell Science Ltd University of Cambridge


Further partner organisations


Fondazione Umberto Veronesi Innova srl Centro Residenziale Universitario die Bertinoro Dynamo Academy